Skip to main content
Caplight Logo









CpG Diagnostics, Inc.

CpG Diagnostics, Inc.

Private
Pasadena, CaliforniaHealthcare & Life Scienceshttps://www.cpgdiagnostics.com/

Last Round

Early Funding

Oct 27, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CpG Diagnostics, Inc. is a biotechnology company that develops epigenetic-based liquid biopsy diagnostic tests for the early detection and management of ovarian cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsyepigenetic testingovarian cancer detectioncell-free DNAcfDNAmethylation analysisprecision diagnosticscancer screeningpelvic mass diagnosisclinical genomicsdiagnostic biomarkermulti-cancer early detectionMCEDAI diagnosticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CpG Diagnostics, Inc. Comparables

Compare CpG Diagnostics, Inc. with similar companies based on industry and business-model similarity.

CpG Diagnostics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenoME Diagnostics Ltd
84%
Aspira Women's Health Inc.
83%
Genece Health
81%

CpG Diagnostics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 27, 2025
AcceleratorSep 1, 2024
Early FundingAug 13, 2024
AcceleratorMay 31, 2022

CpG Diagnostics, Inc. Investors

Notable investors and investment history

CpG Diagnostics, Inc. investors
InvestorRounds
California Life SciencesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 211% MoM.

  • May 17, 2026

    Monthly visitors increased 115% MoM.

CpG Diagnostics, Inc. Filings

Explore SEC and related filing metadata, where available.

CpG Diagnostics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CpG Diagnostics, Inc.'s valuation, stock price, and market status.

Is CpG Diagnostics, Inc. a public or private company?

CpG Diagnostics, Inc. is a private company.

What is the current stock price of CpG Diagnostics, Inc.?

CpG Diagnostics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CpG Diagnostics, Inc. worth (valuation)?

Valuation information for CpG Diagnostics, Inc. is not publicly available.

Can I buy CpG Diagnostics, Inc. stock?

CpG Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CpG Diagnostics, Inc.'s last funding round?

CpG Diagnostics, Inc.'s most recent funding round was Early Funding on October 27, 2025.

Who are the main investors in CpG Diagnostics, Inc.?

Key investors in CpG Diagnostics, Inc. include California Life Sciences.

Will CpG Diagnostics, Inc. IPO soon?

No public IPO plans have been announced for CpG Diagnostics, Inc..

How can I track CpG Diagnostics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CpG Diagnostics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPasadena, California
Employee Range2
Year Founded2020
Last FundingOct 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?